Trends in Lipid, Lipoproteins, and Statin Use Among U.S. Adults
Key result
US lipid profiles and statin use shift following the 2013 risk-based ACC/AHA guidelines.
Key expert perspectives
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
PAPankaj AroraCardiologist, University of Alabama at Birmingham
“Whether those are educational opportunities at the patient level alluding to their fear of taking a statin, or whether there are educational opportunities at the healthcare provider level, there are clear interventions targeting these gaps that can be taken to help improve the dissemination of the 2013 ACC/AHA guidelines.”
“Overall, though, both show a large burden of non- and undertreatment in ASCVD patients, and further efforts to address these gaps are essential.”
PAPankaj AroraCardiologist, University of Alabama at Birmingham
“The guidelines in 2013, as well as the updated ones in 2018, changed the focus from titration and 'get to goal' to a disease- or risk-based assessment. We talk to our patients rather than simply chasing just LDL levels. With the NHANES data, we wanted to see how the guidelines impacted nationwide trends in lipid levels and to really get a sense which way we were headed.”
Abstract
No abstract yet. The journal hasn't published one we can show.
Discussion
No takes yet. Share an insight, caveat, or question.
Cite This Study
Patel et al. (2019) studied this question. Trends in lipid, lipoproteins, and statin use among U.S. adults were characterized following the 2013 ACC/AHA transition to a risk-based approach for lipid management.